Last reviewed · How we verify
Anti-Inflammatory Agents, Non-Steroidal
At a glance
| Generic name | Anti-Inflammatory Agents, Non-Steroidal |
|---|---|
| Also known as | Pain Killer, "Enantyum®" |
| Sponsor | Corporacion Parc Tauli |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis (NA)
- Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis (PHASE4)
- Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older
- Ear Pressure Points Plus Pain Meds for Faster Kidney Stone Pain Relief (NA)
- Does the Development of the Repeated Bout Effect Depend on Oxidative Stress and Inflammation? (NA)
- Metformin Safety and Efficacy in Osteoarthritis. (PHASE3)
- FRONT Block for Quality of Recovery After Total Hip Arthroplasty (NA)
- Association of Erectile Dysfunction With Neuropathic Pain, Disease Activity, and Functional Status in Male Patients With Axial Spondyloarthritis: A Cross-Sectional Observational Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |